Anti-MRSA cephems. Part 3: Additional C-7 acid derivatives
Twenty-seven novel cephalosporin derivatives with activity against methicillin-resistant Staphylococcus aureus (MRSA) are described. The compounds contain novel acid moieties at C-7 that were synthesized using nucleophilic aromatic substitution reactions and Stille couplings. The most interesting co...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2003-01, Vol.11 (2), p.281-291 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 291 |
---|---|
container_issue | 2 |
container_start_page | 281 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 11 |
creator | Springer, Dane M Luh, Bing-Yu Goodrich, Jason T Bronson, Joanne J |
description | Twenty-seven novel cephalosporin derivatives with activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The compounds contain novel acid moieties at C-7 that were synthesized using nucleophilic aromatic substitution reactions and Stille couplings. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg.
Novel C-7 acid cephalosporin derivatives with good activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg.. |
doi_str_mv | 10.1016/S0968-0896(02)00335-8 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmed_primary_12470721</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089602003358</els_id><sourcerecordid>S0968089602003358</sourcerecordid><originalsourceid>FETCH-LOGICAL-e293t-2a8db1a48aa319538a13aed161e24152734b9579ff8f5ee5ecd38f7502d49e653</originalsourceid><addsrcrecordid>eNpF0EtLAzEQwPEgiq3Vj6DsRdBD6uS1m_RSluILKorVc0iTWYy027JZC357-1JPc_kxzPwJOWfQZ8DymwmYXFPQJr8Cfg0ghKL6gHSZzCUVwrBD0v0jHXKS0icAcGnYMekwLgsoOOuSQVm3kT69TsrM4_ID56mfvbimzcQgK0OIbVzUbpaNaJE5H0MWsIkr18YVplNyVLlZwrP97JH3u9u30QMdP98_jsoxRW5ES7nTYcqc1M4JZpTQjgmHgeUMuWSKF0JOjSpMVelKISr0QeiqUMCDNJgr0SMXu73Lr-kcg102ce6ab_v7xBpc7oFL3s2qxtU-pn8nQQrgfO2GO4fra1cRG5t8xNpjiA361oZFtAzsJq_d5rWbdha43ea1WvwAZTloIw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Anti-MRSA cephems. Part 3: Additional C-7 acid derivatives</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Springer, Dane M ; Luh, Bing-Yu ; Goodrich, Jason T ; Bronson, Joanne J</creator><creatorcontrib>Springer, Dane M ; Luh, Bing-Yu ; Goodrich, Jason T ; Bronson, Joanne J</creatorcontrib><description>Twenty-seven novel cephalosporin derivatives with activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The compounds contain novel acid moieties at C-7 that were synthesized using nucleophilic aromatic substitution reactions and Stille couplings. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg.
Novel C-7 acid cephalosporin derivatives with good activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg..</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/S0968-0896(02)00335-8</identifier><identifier>PMID: 12470721</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cephalosporins - chemistry ; Cephalosporins - pharmacology ; Disease Models, Animal ; Lethal Dose 50 ; Medical sciences ; Methicillin Resistance ; Mice ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Staphylococcal Infections - microbiology ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - pathogenicity ; Structure-Activity Relationship</subject><ispartof>Bioorganic & medicinal chemistry, 2003-01, Vol.11 (2), p.281-291</ispartof><rights>2002 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0968-0896(02)00335-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14043022$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12470721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Springer, Dane M</creatorcontrib><creatorcontrib>Luh, Bing-Yu</creatorcontrib><creatorcontrib>Goodrich, Jason T</creatorcontrib><creatorcontrib>Bronson, Joanne J</creatorcontrib><title>Anti-MRSA cephems. Part 3: Additional C-7 acid derivatives</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>Twenty-seven novel cephalosporin derivatives with activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The compounds contain novel acid moieties at C-7 that were synthesized using nucleophilic aromatic substitution reactions and Stille couplings. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg.
Novel C-7 acid cephalosporin derivatives with good activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg..</description><subject>Animals</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cephalosporins - chemistry</subject><subject>Cephalosporins - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Lethal Dose 50</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Mice</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - pathogenicity</subject><subject>Structure-Activity Relationship</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0EtLAzEQwPEgiq3Vj6DsRdBD6uS1m_RSluILKorVc0iTWYy027JZC357-1JPc_kxzPwJOWfQZ8DymwmYXFPQJr8Cfg0ghKL6gHSZzCUVwrBD0v0jHXKS0icAcGnYMekwLgsoOOuSQVm3kT69TsrM4_ID56mfvbimzcQgK0OIbVzUbpaNaJE5H0MWsIkr18YVplNyVLlZwrP97JH3u9u30QMdP98_jsoxRW5ES7nTYcqc1M4JZpTQjgmHgeUMuWSKF0JOjSpMVelKISr0QeiqUMCDNJgr0SMXu73Lr-kcg102ce6ab_v7xBpc7oFL3s2qxtU-pn8nQQrgfO2GO4fra1cRG5t8xNpjiA361oZFtAzsJq_d5rWbdha43ea1WvwAZTloIw</recordid><startdate>20030117</startdate><enddate>20030117</enddate><creator>Springer, Dane M</creator><creator>Luh, Bing-Yu</creator><creator>Goodrich, Jason T</creator><creator>Bronson, Joanne J</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20030117</creationdate><title>Anti-MRSA cephems. Part 3: Additional C-7 acid derivatives</title><author>Springer, Dane M ; Luh, Bing-Yu ; Goodrich, Jason T ; Bronson, Joanne J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e293t-2a8db1a48aa319538a13aed161e24152734b9579ff8f5ee5ecd38f7502d49e653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cephalosporins - chemistry</topic><topic>Cephalosporins - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Lethal Dose 50</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Mice</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - pathogenicity</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Springer, Dane M</creatorcontrib><creatorcontrib>Luh, Bing-Yu</creatorcontrib><creatorcontrib>Goodrich, Jason T</creatorcontrib><creatorcontrib>Bronson, Joanne J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Springer, Dane M</au><au>Luh, Bing-Yu</au><au>Goodrich, Jason T</au><au>Bronson, Joanne J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-MRSA cephems. Part 3: Additional C-7 acid derivatives</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2003-01-17</date><risdate>2003</risdate><volume>11</volume><issue>2</issue><spage>281</spage><epage>291</epage><pages>281-291</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>Twenty-seven novel cephalosporin derivatives with activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The compounds contain novel acid moieties at C-7 that were synthesized using nucleophilic aromatic substitution reactions and Stille couplings. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg.
Novel C-7 acid cephalosporin derivatives with good activity against methicillin-resistant
Staphylococcus aureus (MRSA) are described. The most interesting compound (
6) displayed an MIC
90 against MRSA of 3.7 μg/mL, and an average PD
50 of 3.9 mg/kg..</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12470721</pmid><doi>10.1016/S0968-0896(02)00335-8</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0896 |
ispartof | Bioorganic & medicinal chemistry, 2003-01, Vol.11 (2), p.281-291 |
issn | 0968-0896 1464-3391 |
language | eng |
recordid | cdi_pubmed_primary_12470721 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cephalosporins - chemistry Cephalosporins - pharmacology Disease Models, Animal Lethal Dose 50 Medical sciences Methicillin Resistance Mice Microbial Sensitivity Tests Pharmacology. Drug treatments Staphylococcal Infections - microbiology Staphylococcus aureus - drug effects Staphylococcus aureus - pathogenicity Structure-Activity Relationship |
title | Anti-MRSA cephems. Part 3: Additional C-7 acid derivatives |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T06%3A24%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-MRSA%20cephems.%20Part%203:%20Additional%20C-7%20acid%20derivatives&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Springer,%20Dane%20M&rft.date=2003-01-17&rft.volume=11&rft.issue=2&rft.spage=281&rft.epage=291&rft.pages=281-291&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/S0968-0896(02)00335-8&rft_dat=%3Celsevier_pubme%3ES0968089602003358%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12470721&rft_els_id=S0968089602003358&rfr_iscdi=true |